Antonio Vena - Infectious Diseases

Author Information

Antonio Vena is a prominent researcher in the field of Infectious Diseases, affiliated with the Department of Clinical Microbiology and Infectious Diseases at Hospital General Universitario Gregorio Marañón in Madrid, Spain. His research focuses on various aspects of infectious diseases, including bacterial and fungal infections, diagnostic methods, and emerging treatments.

Research Contributions

Antonio Vena has made significant contributions to the understanding and management of infectious diseases. In 2022 alone, he published extensively on critical topics such as antibiotic treatment for acute bacterial skin and skin structure infections, the incidence and risk factors of Candida auris candidemia, and the diagnostic accuracy of Aspergillus-PCR in critically ill patients. His research has also explored the interplay between Methicillin-resistant Staphylococcus aureus (MRSA) lung infections and COVID-19, as well as novel treatment options for hospital-acquired and ventilator-associated pneumonia.

Aliases

Antonio Vena is known by several aliases in academic publications, including "A Vena" and "A. Vena."

Publication and Citation Metrics

Metric	Value
Citation Count	5752
H-index	39
Paper Count	221

Publications:

Antibiotic treatment of acute bacterial skin and skin structure infections.

DOI: 10.1097/QCO.0000000000000822

Year: 2022

Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors

DOI: 10.1007/s40121-022-00625-9

Year: 2022

Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?

DOI: 10.1097/QCO.0000000000000813

Year: 2022

Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study

DOI: 10.1007/s40121-021-00585-6

Year: 2022

The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series

DOI: 10.1016/j.ajoc.2022.101434

Year: 2022

Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients

DOI: 10.1111/myc.13428

Year: 2022

Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence

DOI: 10.2147/IDR.S318322

Year: 2022

Skin manifestations in patients with coronavirus disease 2019

DOI: 10.1097/QCO.0000000000000816

Year: 2022

New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.

DOI: 10.1055/s-0041-1740605

Year: 2022

Levels of beta-D-Glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.

DOI: 10.1016/j.cmi.2022.02.045

Year: 2022

How Can Yellow Fever Be Prevented?

What is Insect Repellent?

What Certifications are Necessary?

How Do Imaging Tests Aid in Treatment?

What is a Chest CT Scan?

How Are Cases and Controls Selected?

What is Vector Borne Transmission?

How Do Bacterial Infections Spread?

How are HAIs Diagnosed?

How Can ARDS be Prevented in the Context of Infectious Diseases?

Partnered Content Networks

Relevant Topics